Title |
Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
|
---|---|
Published in |
Clinical Pharmacology : Advances and Applications, January 2012
|
DOI | 10.2147/cpaa.s23831 |
Pubmed ID | |
Authors |
Hashemi, HR Ghafarian Shirazi, A Mohammadi, GH Zadeh-Bagheri, KH Noorian, M Malekzadeh |
Abstract |
Depression is a common psychiatric disorder worldwide, including in Iran, and is estimated to affect 10%-15% of the population. Antidepressant drugs can have multiple side effects, so a good choice of drug is important for successful treatment. This study compared the efficacy of nortriptyline with that of fluoxetine in the treatment of patients with major depressive disorder and assessed related factors, including age, gender, and level of education. |
Mendeley readers
The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 48 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 21% |
Researcher | 6 | 13% |
Student > Bachelor | 5 | 10% |
Other | 4 | 8% |
Student > Postgraduate | 3 | 6% |
Other | 8 | 17% |
Unknown | 12 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 19% |
Agricultural and Biological Sciences | 7 | 15% |
Psychology | 6 | 13% |
Social Sciences | 4 | 8% |
Nursing and Health Professions | 3 | 6% |
Other | 4 | 8% |
Unknown | 15 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2011.
All research outputs
#22,889,200
of 25,522,520 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#170
of 179 outputs
Outputs of similar age
#229,034
of 250,632 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#3
of 3 outputs
Altmetric has tracked 25,522,520 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 179 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,632 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.